Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Soft Tissue Sarcoma, Synovial Sarcoma

Robert Maki

MD PhD FACP

🏢Memorial Sloan Kettering Cancer Center🌐USA

Clinical Director of Sarcoma

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Robert Maki is a leading sarcoma oncologist with expertise in synovial sarcoma and soft tissue sarcoma systemic therapy. His clinical research has focused on the SS18-SSX oncofusion driver of synovial sarcoma and exploiting it as a therapeutic target. He has evaluated multiple novel agents in sarcoma clinical trials, including syrosingopine and trabectedin. His contributions span basic sarcoma biology, clinical trial design, and advocacy for rare tumor patients.

Share:

🧪Research Fields 研究领域

synovial sarcoma
soft tissue sarcoma systemic therapy
SS18-SSX fusion
sarcoma immunotherapy
leiomyosarcoma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Robert Maki 的研究动态

Follow Robert Maki's research updates

留下邮箱,当我们发布与 Robert Maki(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment